XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3Close
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Sep. 28, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 4,645 $ 8,077
Short-term investments 2,000 3
Accounts receivable, less allowances of $204 and $193 8,255 8,221
Inventories 5,430 5,088
Contract assets, net 1,541 1,443
Other current assets 1,911 1,757
Total current assets 23,783 24,589
Property, plant and equipment, net 9,412 9,448
Acquisition-related intangible assets, net 16,262 16,670
Other assets 4,180 3,999
Goodwill 46,726 44,020
Total assets 100,364 98,726 CloseClose
Current liabilities:     Close
Short-term obligations and current maturities of long-term obligations 4,116 3,609 Close
Accounts payable 2,606 2,872 Close
Accrued payroll and employee benefits 1,823 1,596 Close
Contract liabilities 2,663 2,689 Close
Other accrued expenses 3,393 3,246 Close
Total current liabilities 14,601 14,012
Deferred income taxes 1,123 1,922 Close
Other long-term liabilities 4,343 4,642 Close
Long-term obligations 31,197 31,308 Close
Redeemable noncontrolling interest 127 118 Close
Thermo Fisher Scientific Inc. shareholders’ equity:    
Total Liabilities 51264.0 51884.0 0 0 0 Close
Preferred stock, $100 par value, 50,000 shares authorized; none issued 0 0 Close
Common stock, $1 par value, 1,200,000,000 shares authorized; 443,676,411 and 442,188,634 shares issued 444 442
Capital in excess of par value 17,831 17,286
Retained earnings 51,421 47,364
Treasury stock at cost, 61,176,146 and 55,541,290 shares (18,227) (15,133)
Accumulated other comprehensive income/(loss) (2,477) (3,224)
Total Thermo Fisher Scientific Inc. shareholders’ equity 48,992 46,735
Noncontrolling interests (20) (11)
Total equity 48,972 46,724 CloseClose
Total liabilities, redeemable noncontrolling interest and equity $ 100,364 $ 98,726